Cargando…

The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies

BACKGROUND: Several authors have hypothesized that adverse drug events (ADEs) upon switching from reference biologics to biosimilar products are related to the nocebo effect. However, a thorough and current review of the existing literature has not been conducted. OBJECTIVE: To evaluate if patient a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Odinet, Johlee S., Day, Chelsea E., Cruz, Jennifer L., Heindel, Gregory A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2018
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398229/ https://www.ncbi.nlm.nih.gov/pubmed/30247100 http://dx.doi.org/10.18553/jmcp.2018.24.10.952

Ejemplares similares

Nocebo in Biosimilars and Generics in Neurology: A Systematic Review
por: Spanou, Ioanna, et al.
Publicado: (2019)

Treatment Outcomes with Biosimilars: Be Aware of the Nocebo Effect
por: Rezk, Mourad F., et al.
Publicado: (2017)

The Clinical Implications of Nocebo Effects for Biosimilar Therapy
por: Colloca, Luana, et al.
Publicado: (2019)

To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars
por: Rezk, Mourad F., et al.
Publicado: (2018)

Correction to: To See or NOsee: The Debate on the Nocebo Effect and Optimizing the Use of Biosimilars
por: Rezk, Mourad F., et al.
Publicado: (2018)

The role of the Nocebo effect in the use of biosimilars in routine rheumatology clinical practice
por: Kravvariti, Evrydiki, et al.
Publicado: (2019)

Effects of Open- and Closed-Label Nocebo and Placebo Suggestions on Itch and Itch Expectations
por: Meeuwis, Stefanie H., et al.
Publicado: (2019)

FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension
por: Genovese, Mark C., et al.
Publicado: (2019)

Switching from One Biosimilar to Another Biosimilar of the Same Reference Biologic: A Systematic Review of Studies
por: Cohen, Hillel P., et al.
Publicado: (2022)

Open- and Closed-Label Placebo and Nocebo Suggestions About a Sham Transdermal Patch
por: Meeuwis, Stefanie H., et al.
Publicado: (2021)

Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
por: Kristensen, Lars Erik, et al.
Publicado: (2018)

Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review
por: McKinnon, Ross A., et al.
Publicado: (2018)

Patients Retransitioning from Biosimilar TNFα Inhibitor to the Corresponding Originator After Initial Transitioning to the Biosimilar: A Systematic Review
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

Biosimilars for the Treatment of Cancer: A Systematic Review of Published Evidence
por: Jacobs, Ira, et al.
Publicado: (2017)

Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar
por: Petit, Juliette, et al.
Publicado: (2021)

Clinical trials for authorized biosimilars in the European Union: a systematic review
por: Mielke, Johanna, et al.
Publicado: (2016)

Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer
por: Triantafyllidi, Eleni, et al.
Publicado: (2022)

Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence
por: Jacobs, Ira, et al.
Publicado: (2016)

Placebo – Nocebo
por: Mosser, Astrid
Publicado: (2022)

Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
por: Jacobs, Ira, et al.
Publicado: (2016)

Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes
por: Cohen, Hillel P., et al.
Publicado: (2018)

Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab
por: Feagan, Brian G., et al.
Publicado: (2018)

Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology?
por: Fleischmann, Roy, et al.
Publicado: (2020)

The nocebo effect of drugs
por: Planès, Sara, et al.
Publicado: (2016)

Indian Biosimilars and Vaccines at Crossroads–Replicating the Success of Pharmagenerics
por: Panda, Sunita, et al.
Publicado: (2023)

Learned Nocebo Effects on Cutaneous Sensations of Pain and Itch: A Systematic Review and Meta-analysis of Experimental Behavioral Studies on Healthy Humans
por: Thomaidou, Mia A., et al.
Publicado: (2023)

Learning pain from others: a systematic review and meta-analysis of studies on placebo hypoalgesia and nocebo hyperalgesia induced by observational learning
por: Meeuwis, Stefanie H., et al.
Publicado: (2023)

Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effects
por: Smolen, Josef S, et al.
Publicado: (2021)

Information About the Optimism of a Placebo/Nocebo Provider and Placebo/Nocebo Side Effects
por: Schlintl, Carina, et al.
Publicado: (2021)

Susceptibility to Nocebo Hyperalgesia, Dispositional Optimism, and Trait Anxiety as Predictors of Nocebo Hyperalgesia Reduction
por: Karacaoglu, Merve, et al.
Publicado: (2023)

Nocebo effects in the treatment of endometriosis
por: Thiel, Peter, et al.
Publicado: (2021)

Laparoscopic versus open inguinal hernia repair in children: A systematic review
por: Zhao, Jie, et al.
Publicado: (2022)

Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials
por: Lang-Illievich, Kordula, et al.
Publicado: (2023)

A systematic review of sex differences in the placebo and the nocebo effect
por: Vambheim, Sara M, et al.
Publicado: (2017)

Patients’ experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study
por: Haas, Julia W., et al.
Publicado: (2022)

Experimental Assessment of Nocebo Effects and Nocebo Side Effects: Definitions, Study Design, and Implications for Psychiatry and Beyond
por: Faasse, Kate, et al.
Publicado: (2019)

Nocebo effects by providing informed consent in shared decision making? Not necessarily: a randomized pilot-trial using an open-label placebo approach
por: Holzhüter, Fabian, et al.
Publicado: (2020)

Systematic review and meta-analysis of cost-effectiveness of minimally invasive versus open pancreatic resections
por: Lee, Suhyun, et al.
Publicado: (2023)

The "nocebo effect" in drug hypersensitivity diagnosis
por: Bommarito, Luisa, et al.
Publicado: (2014)

Fear of pain potentiates nocebo hyperalgesia
por: Aslaksen, Per M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m7ji3u2nfbt1vk5918nktsmahd